Proteomics, lipidomics, and lipid profiles Specific plasma proteomic signatures have been identified as markers of cardiovascular risk in MASLD
A healthcare provider can help assess these risks and make a plan that works for the individual
A study on the risk of suicidality by McIntyre and colleagues, a systematic review published in *Expert Opinion on Drug Safety*, found that, based on the available evidence, there is no clear increased risk of suicidal behaviour among GLP-1 users
Moreover, CSF norepinephrine concentrations are shown to be more significantly and positively link with the severity of PTSD symptoms, rather than plasma norepinephrine concentrations (182)
Understanding why they happen can help you take steps to reduce them
Our study has limitations: the generalizability of the results of the SELECT trial to a real-world clinical population of patients with overweight or obesity and established CVD or to a population without established CVD is unknown, and the generalizability of our results is similarly uncertain